Background Nicotine replacement therapy (NRT) aims to temporarily replace much of the
nicotine from cigarettes to reduce motivation to smoke and nicotine withdrawal symptoms …

Background Smoking contributes to reasons for hospitalisation, and the period of
hospitalisation may be a good time to provide help with quitting. Objectives To determine the …

Objective To evaluate the impact of telling patients their estimated spirometric lung age as
an incentive to quit smoking. Design Randomised controlled trial. Setting Five general …

Background Smoking remains the leading preventable cause of premature deaths. Several
pharmacological interventions now exist to aid smokers in cessation. These include Nicotine …

Smoking cessation is the one of the most important ways to improve the prognosis of
patients with respiratory disease. The Task Force on guidelines for smoking cessation in …

Objectives To analyse evidence on the effectiveness of intensive NHS treatments for
smoking cessation in helping smokers to quit. Methods A systematic review of studies …

Background: While smoking cessation interventions have been shown to work, questions
remain about how to increase their efficacy. Purpose: To examine strategies for effective …

Background: Chronic obstructive pulmonary disease (COPD), usually caused by tobacco
smoking, is one of the leading causes of morbidity and mortality. Smoking cessation at an …

Background Nicotine replacement therapy (NRT) is the most common form of smoking
cessation pharmacotherapy and has proven efficacy for the treatment of tobacco …

Background Cigarette smoking is one of the leading causes of early death. Varenicline
[Champix (UK), Pfizer Europe MA EEIG, Brussels, Belgium; or Chantix (USA), Pfizer Inc …